APO Research
Talk to an analyst

APO RESEARCH · REPORT

Furazolidone

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Furazolidone Industry Growth and Trends Forecast to 2032

19 December 2025108 pages

Choose your research edition.

Industry ResearchFurazolidone Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Furazolidone Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Furazolidone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Furazolidone Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Furazolidone Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Furazolidone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Furazolidone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Furazolidone is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Furazolidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Furazolidone include Becton, Dickinson and Company (BD), Daiichi Sankyo, Ferring, Geo-Med, GrÜNenthal Gmbh, Keyfarm, KPL Pharma, Marvi and Standpharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Furazolidone market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Furazolidone market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Furazolidone market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Furazolidone.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Furazolidone market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Furazolidone Market by Company

Becton, Dickinson and Company (BD)

Daiichi Sankyo

Ferring

Geo-Med

GrÜNenthal Gmbh

Keyfarm

KPL Pharma

Marvi

Standpharm

Teva

Furazolidone Segment by Type

Pharma Grade

Industrial Grade

Others

Furazolidone Segment by Application

Pharmacy

Industry

Furazolidone Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Furazolidone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Furazolidone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Furazolidone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Furazolidone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Furazolidone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Pharma Grade Table 2. Major Company of Industrial Grade Table 3. Major Company of Others Table 4. Global Furazolidone Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Furazolidone Sales by Type (2021-2026) & (K Units) Table 6. Global Furazolidone Sales Market Share in Volume by Type (2021-2026) Table 7. Global Furazolidone Sales by Type (2021-2026) & (US$ Million) Table 8. Global Furazolidone Sales Market Share in Value by Type (2021-2026) Table 9. Global Furazolidone Price by Type (2021-2026) & (US$/Unit) Table 10. Global Furazolidone Sales by Type (2027-2032) & (K Units) Table 11. Global Furazolidone Sales Market Share in Volume by Type (2027-2032) Table 12. Global Furazolidone Sales by Type (2027-2032) & (US$ Million) Table 13. Global Furazolidone Sales Market Share in Value by Type (2027-2032) Table 14. Global Furazolidone Price by Type (2027-2032) & (US$/Unit) Table 15. North America Furazolidone Sales by Type (2021-2026) & (K Units) Table 16. North America Furazolidone Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Furazolidone Sales by Type (2021-2026) & (K Units) Table 18. Europe Furazolidone Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Furazolidone Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Furazolidone Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Furazolidone Sales by Type (2021-2026) & (K Units) Table 22. Latin America Furazolidone Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Furazolidone Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Furazolidone Sales by Type (2021-2026) & (US$ Million) Table 25. Furazolidone Industry Trends Table 26. Furazolidone Industry Drivers Table 27. Furazolidone Industry Opportunities and Challenges Table 28. Furazolidone Industry Restraints Table 29. Global Furazolidone Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Furazolidone Revenue Market Share by Company (2021-2026) Table 31. Global Furazolidone Sales by Company (2021-2026) & (K Units) Table 32. Global Furazolidone Sales Share by Company (2021-2026) Table 33. Global Furazolidone Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Furazolidone Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Furazolidone Major Company Production Sites and Headquarters Table 36. Global Furazolidone Company, Product Type & Application Table 37. Global Furazolidone Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Furazolidone by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Furazolidone Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Furazolidone Sales by Region (2021-2026) & (K Units) Table 42. Global Furazolidone Sales Market Share in Volume by Region (2021-2026) Table 43. Global Furazolidone Sales by Region (2021-2026) & (US$ Million) Table 44. Global Furazolidone Sales Market Share in Value by Region (2021-2026) Table 45. Global Furazolidone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Furazolidone Sales by Region (2027-2032) & (K Units) Table 47. Global Furazolidone Sales Market Share in Volume by Region (2027-2032) Table 48. Global Furazolidone Sales by Region (2027-2032) & (US$ Million) Table 49. Global Furazolidone Sales Market Share in Value by Region (2027-2032) Table 50. Global Furazolidone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Furazolidone Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Furazolidone Sales by Application (2021-2026) & (K Units) Table 53. Global Furazolidone Sales Market Share in Volume by Application (2021-2026) Table 54. Global Furazolidone Sales by Application (2021-2026) & (US$ Million) Table 55. Global Furazolidone Sales Market Share in Value by Application (2021-2026) Table 56. Global Furazolidone Price by Application (2021-2026) & (US$/Unit) Table 57. Global Furazolidone Sales by Application (2027-2032) & (K Units) Table 58. Global Furazolidone Sales Market Share in Volume by Application (2027-2032) Table 59. Global Furazolidone Sales by Application (2027-2032) & (US$ Million) Table 60. Global Furazolidone Sales Market Share in Value by Application (2027-2032) Table 61. Global Furazolidone Price by Application (2027-2032) & (US$/Unit) Table 62. North America Furazolidone Sales by Application (2021-2026) & (K Units) Table 63. North America Furazolidone Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Furazolidone Sales by Application (2021-2026) & (K Units) Table 65. Europe Furazolidone Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Furazolidone Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Furazolidone Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Furazolidone Sales by Application (2021-2026) & (K Units) Table 69. Latin America Furazolidone Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Furazolidone Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Furazolidone Sales by Application (2021-2026) & (US$ Million) Table 72. Becton, Dickinson and Company (BD) Company Information Table 73. Becton, Dickinson and Company (BD) Business Overview Table 74. Becton, Dickinson and Company (BD) Furazolidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Becton, Dickinson and Company (BD) Furazolidone Product Portfolio Table 76. Becton, Dickinson and Company (BD) Recent Development Table 77. Daiichi Sankyo Company Information Table 78. Daiichi Sankyo Business Overview Table 79. Daiichi Sankyo Furazolidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Daiichi Sankyo Furazolidone Product Portfolio Table 81. Daiichi Sankyo Recent Development Table 82. Ferring Company Information Table 83. Ferring Business Overview Table 84. Ferring Furazolidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Ferring Furazolidone Product Portfolio Table 86. Ferring Recent Development Table 87. Geo-Med Company Information Table 88. Geo-Med Business Overview Table 89. Geo-Med Furazolidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Geo-Med Furazolidone Product Portfolio Table 91. Geo-Med Recent Development Table 92. GrÜNenthal Gmbh Company Information Table 93. GrÜNenthal Gmbh Business Overview Table 94. GrÜNenthal Gmbh Furazolidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. GrÜNenthal Gmbh Furazolidone Product Portfolio Table 96. GrÜNenthal Gmbh Recent Development Table 97. Keyfarm Company Information Table 98. Keyfarm Business Overview Table 99. Keyfarm Furazolidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Keyfarm Furazolidone Product Portfolio Table 101. Keyfarm Recent Development Table 102. KPL Pharma Company Information Table 103. KPL Pharma Business Overview Table 104. KPL Pharma Furazolidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. KPL Pharma Furazolidone Product Portfolio Table 106. KPL Pharma Recent Development Table 107. Marvi Company Information Table 108. Marvi Business Overview Table 109. Marvi Furazolidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Marvi Furazolidone Product Portfolio Table 111. Marvi Recent Development Table 112. Standpharm Company Information Table 113. Standpharm Business Overview Table 114. Standpharm Furazolidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Standpharm Furazolidone Product Portfolio Table 116. Standpharm Recent Development Table 117. Teva Company Information Table 118. Teva Business Overview Table 119. Teva Furazolidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Teva Furazolidone Product Portfolio Table 121. Teva Recent Development Table 122. North America Furazolidone Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. North America Furazolidone Sales by Country (2021-2026) & (K Units) Table 124. North America Furazolidone Sales Market Share by Country (2021-2026) Table 125. North America Furazolidone Sales Forecast by Country (2027-2032) & (K Units) Table 126. North America Furazolidone Sales Market Share Forecast by Country (2027-2032) Table 127. North America Furazolidone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. North America Furazolidone Market Size by Country (2021-2026) & (US$ Million) Table 129. North America Furazolidone Market Share by Country (2021-2026) Table 130. North America Furazolidone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. North America Furazolidone Market Share Forecast by Country (2027-2032) Table 132. Europe Furazolidone Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Europe Furazolidone Sales by Country (2021-2026) & (K Units) Table 134. Europe Furazolidone Sales Market Share by Country (2021-2026) Table 135. Europe Furazolidone Sales Forecast by Country (2027-2032) & (K Units) Table 136. Europe Furazolidone Sales Market Share Forecast by Country (2027-2032) Table 137. Europe Furazolidone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Europe Furazolidone Market Size by Country (2021-2026) & (US$ Million) Table 139. Europe Furazolidone Market Share by Country (2021-2026) Table 140. Europe Furazolidone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Europe Furazolidone Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Furazolidone Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Furazolidone Sales by Country (2021-2026) & (K Units) Table 144. Asia-Pacific Furazolidone Sales Market Share by Country (2021-2026) Table 145. Asia-Pacific Furazolidone Sales Forecast by Country (2027-2032) & (K Units) Table 146. Asia-Pacific Furazolidone Sales Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Furazolidone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Furazolidone Market Size by Country (2021-2026) & (US$ Million) Table 149. Asia-Pacific Furazolidone Market Share by Country (2021-2026) Table 150. Asia-Pacific Furazolidone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Asia-Pacific Furazolidone Market Share Forecast by Country (2027-2032) Table 152. Latin America Furazolidone Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Latin America Furazolidone Sales by Country (2021-2026) & (K Units) Table 154. Latin America Furazolidone Sales Market Share by Country (2021-2026) Table 155. Latin America Furazolidone Sales Forecast by Country (2027-2032) & (K Units) Table 156. Latin America Furazolidone Sales Market Share Forecast by Country (2027-2032) Table 157. Latin America Furazolidone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Latin America Furazolidone Market Size by Country (2021-2026) & (US$ Million) Table 159. Latin America Furazolidone Market Share by Country (2021-2026) Table 160. Latin America Furazolidone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Latin America Furazolidone Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Furazolidone Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Furazolidone Sales by Country (2021-2026) & (K Units) Table 164. Middle East and Africa Furazolidone Sales Market Share by Country (2021-2026) Table 165. Middle East and Africa Furazolidone Sales Forecast by Country (2027-2032) & (K Units) Table 166. Middle East and Africa Furazolidone Sales Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Furazolidone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Furazolidone Market Size by Country (2021-2026) & (US$ Million) Table 169. Middle East and Africa Furazolidone Market Share by Country (2021-2026) Table 170. Middle East and Africa Furazolidone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Middle East and Africa Furazolidone Market Share Forecast by Country (2027-2032) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Furazolidone Distributors List Table 175. Furazolidone Customers List Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. Furazolidone Image Figure 2. Global Furazolidone Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Furazolidone Market Size (2021-2032) & (US$ Million) Figure 4. Global Furazolidone Sales (2021-2032) & (K Units) Figure 5. Pharma Grade Image Figure 6. Global Pharma Grade Sales YoY Growth (2021-2032) & (K Units) Figure 7. Industrial Grade Image Figure 8. Global Industrial Grade Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Furazolidone Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Furazolidone Market Share by Type 2025 VS 2032 Figure 13. North America Furazolidone Sales Market Share in Volume by Type in 2025 Figure 14. North America Furazolidone Sales Market Share in Value by Type in 2025 Figure 15. Europe Furazolidone Sales Market Share in Volume by Type in 2025 Figure 16. Europe Furazolidone Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Furazolidone Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Furazolidone Sales Market Share in Value by Type in 2025 Figure 19. Latin America Furazolidone Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Furazolidone Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Furazolidone Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Furazolidone Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Furazolidone Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Pharmacy Image Figure 26. Global Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 27. Industry Image Figure 28. Global Industry Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Furazolidone Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Furazolidone Market Share by Application 2025 VS 2032 Figure 31. North America Furazolidone Sales Market Share in Volume by Application in 2025 Figure 32. North America Furazolidone Sales Market Share in Value by Application in 2025 Figure 33. Europe Furazolidone Sales Market Share in Volume by Application in 2025 Figure 34. Europe Furazolidone Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Furazolidone Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Furazolidone Sales Market Share in Value by Application in 2025 Figure 37. Latin America Furazolidone Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Furazolidone Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Furazolidone Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Furazolidone Sales Market Share in Value by Application in 2025 Figure 41. North America Furazolidone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Furazolidone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Furazolidone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Furazolidone Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Furazolidone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Furazolidone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Furazolidone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Furazolidone Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Furazolidone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Furazolidone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Furazolidone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Furazolidone Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Furazolidone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Furazolidone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Furazolidone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Furazolidone Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Furazolidone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Furazolidone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Furazolidone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Furazolidone Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Furazolidone Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Furazolidone Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Pharma Grade
  • Industrial Grade
  • Others
Applications
  • Pharmacy
  • Industry
Companies covered
  • Becton, Dickinson and Company (BD)
  • Daiichi Sankyo
  • Ferring
  • Geo-Med
  • GrÜNenthal Gmbh
  • Keyfarm
  • KPL Pharma
  • Marvi
  • Standpharm
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Furazolidone Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Furazolidone Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Furazolidone Market by Type
  6. 1.3.1 Pharma Grade
  7. 1.3.2 Industrial Grade
  8. 1.3.3 Others
  9. 1.4 Global Furazolidone Market Size by Type
  10. 1.4.1 Global Furazolidone Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Furazolidone Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Furazolidone Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Furazolidone Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Furazolidone Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Furazolidone Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Furazolidone Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Furazolidone Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Furazolidone Industry Trends
  2. 2.2 Furazolidone Industry Drivers
  3. 2.3 Furazolidone Industry Opportunities and Challenges
  4. 2.4 Furazolidone Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Furazolidone Revenue (2021-2026)
  2. 3.2 Global Top Players by Furazolidone Sales (2021-2026)
  3. 3.3 Global Top Players by Furazolidone Price (2021-2026)
  4. 3.4 Global Furazolidone Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Furazolidone Major Company Production Sites & Headquarters
  6. 3.6 Global Furazolidone Company, Product Type & Application
  7. 3.7 Global Furazolidone Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Furazolidone Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Furazolidone Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Furazolidone Tier 1, Tier 2, and Tier 3
4 Furazolidone Regional Status and Outlook
  1. 4.1 Global Furazolidone Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Furazolidone Historic Market Size by Region
  3. 4.2.1 Global Furazolidone Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Furazolidone Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Furazolidone Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Furazolidone Forecasted Market Size by Region
  7. 4.3.1 Global Furazolidone Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Furazolidone Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Furazolidone Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Furazolidone by Application
  1. 5.1 Furazolidone Market by Application
  2. 5.1.1 Pharmacy
  3. 5.1.2 Industry
  4. 5.2 Global Furazolidone Market Size by Application
  5. 5.2.1 Global Furazolidone Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Furazolidone Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Furazolidone Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Furazolidone Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Furazolidone Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Furazolidone Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Furazolidone Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Furazolidone Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Becton, Dickinson and Company (BD)
  2. 6.1.1 Becton, Dickinson and Company (BD) Company Information
  3. 6.1.2 Becton, Dickinson and Company (BD) Business Overview
  4. 6.1.3 Becton, Dickinson and Company (BD) Furazolidone Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Becton, Dickinson and Company (BD) Furazolidone Product Portfolio
  6. 6.1.5 Becton, Dickinson and Company (BD) Recent Developments
  7. 6.2 Daiichi Sankyo
  8. 6.2.1 Daiichi Sankyo Company Information
  9. 6.2.2 Daiichi Sankyo Business Overview
  10. 6.2.3 Daiichi Sankyo Furazolidone Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Daiichi Sankyo Furazolidone Product Portfolio
  12. 6.2.5 Daiichi Sankyo Recent Developments
  13. 6.3 Ferring
  14. 6.3.1 Ferring Company Information
  15. 6.3.2 Ferring Business Overview
  16. 6.3.3 Ferring Furazolidone Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Ferring Furazolidone Product Portfolio
  18. 6.3.5 Ferring Recent Developments
  19. 6.4 Geo-Med
  20. 6.4.1 Geo-Med Company Information
  21. 6.4.2 Geo-Med Business Overview
  22. 6.4.3 Geo-Med Furazolidone Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Geo-Med Furazolidone Product Portfolio
  24. 6.4.5 Geo-Med Recent Developments
  25. 6.5 GrÜNenthal Gmbh
  26. 6.5.1 GrÜNenthal Gmbh Company Information
  27. 6.5.2 GrÜNenthal Gmbh Business Overview
  28. 6.5.3 GrÜNenthal Gmbh Furazolidone Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 GrÜNenthal Gmbh Furazolidone Product Portfolio
  30. 6.5.5 GrÜNenthal Gmbh Recent Developments
  31. 6.6 Keyfarm
  32. 6.6.1 Keyfarm Company Information
  33. 6.6.2 Keyfarm Business Overview
  34. 6.6.3 Keyfarm Furazolidone Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Keyfarm Furazolidone Product Portfolio
  36. 6.6.5 Keyfarm Recent Developments
  37. 6.7 KPL Pharma
  38. 6.7.1 KPL Pharma Company Information
  39. 6.7.2 KPL Pharma Business Overview
  40. 6.7.3 KPL Pharma Furazolidone Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 KPL Pharma Furazolidone Product Portfolio
  42. 6.7.5 KPL Pharma Recent Developments
  43. 6.8 Marvi
  44. 6.8.1 Marvi Company Information
  45. 6.8.2 Marvi Business Overview
  46. 6.8.3 Marvi Furazolidone Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Marvi Furazolidone Product Portfolio
  48. 6.8.5 Marvi Recent Developments
  49. 6.9 Standpharm
  50. 6.9.1 Standpharm Company Information
  51. 6.9.2 Standpharm Business Overview
  52. 6.9.3 Standpharm Furazolidone Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Standpharm Furazolidone Product Portfolio
  54. 6.9.5 Standpharm Recent Developments
  55. 6.10 Teva
  56. 6.10.1 Teva Company Information
  57. 6.10.2 Teva Business Overview
  58. 6.10.3 Teva Furazolidone Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Teva Furazolidone Product Portfolio
  60. 6.10.5 Teva Recent Developments
7 North America by Country
  1. 7.1 North America Furazolidone Sales by Country
  2. 7.1.1 North America Furazolidone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Furazolidone Sales by Country (2021-2026)
  4. 7.1.3 North America Furazolidone Sales Forecast by Country (2027-2032)
  5. 7.2 North America Furazolidone Market Size by Country
  6. 7.2.1 North America Furazolidone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Furazolidone Market Size by Country (2021-2026)
  8. 7.2.3 North America Furazolidone Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Furazolidone Sales by Country
  2. 8.1.1 Europe Furazolidone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Furazolidone Sales by Country (2021-2026)
  4. 8.1.3 Europe Furazolidone Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Furazolidone Market Size by Country
  6. 8.2.1 Europe Furazolidone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Furazolidone Market Size by Country (2021-2026)
  8. 8.2.3 Europe Furazolidone Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Furazolidone Sales by Country
  2. 9.1.1 Asia-Pacific Furazolidone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Furazolidone Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Furazolidone Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Furazolidone Market Size by Country
  6. 9.2.1 Asia-Pacific Furazolidone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Furazolidone Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Furazolidone Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Furazolidone Sales by Country
  2. 10.1.1 South America Furazolidone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Furazolidone Sales by Country (2021-2026)
  4. 10.1.3 South America Furazolidone Sales Forecast by Country (2027-2032)
  5. 10.2 South America Furazolidone Market Size by Country
  6. 10.2.1 South America Furazolidone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Furazolidone Market Size by Country (2021-2026)
  8. 10.2.3 South America Furazolidone Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Furazolidone Sales by Country
  2. 11.1.1 Middle East and Africa Furazolidone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Furazolidone Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Furazolidone Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Furazolidone Market Size by Country
  6. 11.2.1 Middle East and Africa Furazolidone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Furazolidone Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Furazolidone Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Furazolidone Value Chain Analysis
  2. 12.1.1 Furazolidone Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Furazolidone Production Mode & Process
  7. 12.2 Furazolidone Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Furazolidone Distributors
  10. 12.2.3 Furazolidone Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst